PT - JOURNAL ARTICLE AU - Law, Mikaela AU - Pickering, Isabella AU - Humphrey, Gayl AU - Sebaratnam, Gabrielle AU - Schamberg, Gabriel AU - Simpson, Katie AU - Varghese, Chris AU - Du, Peng AU - Daker, Charlotte AU - Huang, I-Hsuan AU - Khalsa, Sahib S. AU - Gharibans, Armen AU - O’Grady, Greg AU - Andrews, Christopher N. AU - Calder, Stefan TI - Development and Validation of the Alimetry® Gut-Brain Wellbeing Survey: A novel patient-reported mental health scale for patients with chronic gastroduodenal symptoms AID - 10.1101/2023.09.25.23296105 DP - 2024 Jan 01 TA - medRxiv PG - 2023.09.25.23296105 4099 - http://medrxiv.org/content/early/2024/02/01/2023.09.25.23296105.short 4100 - http://medrxiv.org/content/early/2024/02/01/2023.09.25.23296105.full AB - Objective There is currently a lack of validated questionnaires designed specifically to assess mental health within patients with chronic gastroduodenal symptoms. This research describes the multi-phase process used to develop and validate a novel mental health scale for patients with chronic gastroduodenal symptoms, the Alimetry® Gut-Brain Wellbeing (AGBW) Survey.Methods A patient-centred multi-phase process was implemented. In Phase 1, the most relevant concepts for this patient population were selected from existing mental health scales, using data from 79 patients. In Phase 2, an interdisciplinary panel of experts generated scale items. In Phase 3, the scale underwent pre-testing with gastroenterologists (n=9), health psychologists (n=3), and patients (n=12), with feedback incorporated over multiple rounds. Lastly, the psychometric properties of the scale were assessed in a sample of 311 patients via an online survey.Results The AGBW Survey comprises a patient preface, 10 close-ended questions, and an optional open-ended question. This multidimensional scale assesses general mental health, alongside specific subscales relating to depression, stress, and anxiety. The subscale and total scores demonstrated high internal consistency (α= .91 for the total scale; α= .72-.86 for subscales) and good convergent, divergent, concurrent validity, and known groups validity, with large effect sizes.Conclusions The AGBW Survey is a brief, valid, and reliable scale for assessing mental health in patients with chronic gastroduodenal symptoms. It can be used as a tool to complement physiological tests and has the potential to guide psychological referrals, inform multidisciplinary management, and evaluate treatment outcomes.Competing Interest StatementGOG and AG hold grants and intellectual property in the field of gastrointestinal electrophysiology and are Directors in Alimetry Ltd. GOG is also a Director in The Insides Company. ML, IP, GS, GS, PD, CD, CNA, and SC are members of Alimetry Ltd. GH holds options in Alimetry. The remaining authors have no relevant conflicts to declare.Clinical TrialACTRN12623000385640Funding StatementThis study is funded by a New Zealand Health Research Council Programme Grant 3715588.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics was obtained via the Auckland Health Research Ethics Committee (AHREC; AH1130), The University of Calgary Conjoint Health Research Ethics Board (REB19-1925), and the Human Research Ethics Committee at Western Sydney (H13541).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe data that support the findings of this study are available from the corresponding author, upon reasonable request.